Paraoxonase 2 (PON2) decreases high glucose-induced macrophage triglycerides (TG) accumulation, via inhibition of NADPH-oxidase and DGAT1 activity: Studies in PON2-deficient mice

Atherosclerosis

Volumn 208, Issue 2, 2010, Pages 390-395

  Meilin, Edna ^a   Aviram, Michael ^a   Hayek, Tony ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Diabetes mellitus; Macrophages; NADPH oxidase; Oxidative stress; Paraoxonase 2 (PON2); Triglycerides

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; APOCYNIN; ARYLDIALKYLPHOSPHATASE 2; DIACYLGLYCEROL ACYLTRANSFERASE 1; GLUCOSE; LOW DENSITY LIPOPROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; C57BL 6 MOUSE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME INHIBITION; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; MICROSOME; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ARYLDIALKYLPHOSPHATASE; CHOLESTEROL; DIABETES MELLITUS, EXPERIMENTAL; DIACYLGLYCEROL O-ACYLTRANSFERASE; GLUCOSE; MACROPHAGES; MICE; MICE, INBRED C57BL; MICROSOMES; NADPH OXIDASE; OXIDATIVE STRESS; OXYGEN; POLYMERASE CHAIN REACTION; TRIGLYCERIDES;

EID: 75049083347     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.07.057     Document Type: Article

References (30)

1. Hayek T., Hussein K., Aviram M., et al. Macrophage foam-cell formation in streptozotocin-induced diabetic mice: stimulatory effect of glucose. Atherosclerosis 183 (2005) 25-33
2. Hayek T., Kaplan M., Kerry R., and Aviram M. Macrophage NADPH oxidase activation, impaired cholesterol fluxes and increased cholesterol biosynthesis in diabetic mice: a stimulating role for D glucose. Atherosclerosis 195 (2007) 277-286
3. Rosenberg O., Shiner M., Aviram M., and Hayek T. Paraoxonase 1 attenuates diabetes development in mice through its antioxidative properties. Free Radic Biol Med 44 (2008) 1951-1959
4. Harja E., Bu D.X., Hudson B.I., et al. Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE mice. J Clin Invest 118 (2008) 183-194
5. Carmena R., Duriez P., and Fruchart J.C. Atherogenic lipoprotein particles in atherosclerosis. Circulation 109 (2004) III2-III7
6. Ginsberg N.G., Zhang Y.L., and Hernandez-Ono A. Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res 36 (2005) 232-240
7. Tiwari R.L., Singh Y., and Barthwal M.K. Macrophages: an elusive yet emerging therapeutic target of atherosclerosis. Med Res Rev 28 (2008) 483-544
8. Aronis A., Madar Z., and Tirosh O. Mechanism underlying oxidative stress-mediated lipotoxicity: exposure of J774. 2 macrophages to triacylglycerols facilities mitochondrial reactive oxygen species production and cellular necrosis. Free Radic Biol Med 38 (2005) 1221-1230
9. Draganov D.I., Teiber J.F., Speelman A., Osawa Y., Sunahara R., and La Du B.N. Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities. J Lipid Res 46 (2005) 1239-1247
10. Marsillach J., Machness B., Machness M., et al. Immunohistochemical analysis of paraoxonases 1, 2 and 3 expression in normal mouse tissue. Free Radic Biol Med 45 (2008) 146-157
11. Hong-Liang L., De-Pei L., and Chih-Chuan L. Paraoxonase gene polymorphisms, oxidative stress, and diseases. J Mol Med 81 (2003) 766-779
12. Mackness B., Mcelduff P., and Mackness M.I. The paraoxonase 2-310 polymorphism is associated with the presence of microvascular complications in diabetes mellitus. J Intern Med 258 (2005) 363-368
13. Rosenblat M., Coleman R., Reddy S.T., and Aviram M. Paraoxonase 2 attenuates macrophage triglyceride accumulation via inhibition of diacylglycerol acyltransferase 1 (DGAT1), the rate limiting enzyme in triglyceride biosynthesis. J Lipid Res 50 (2009) 870-879
14. Ng C.J., Wadleigh D.J., Gangopadhyay A., et al. PON2 is a ubiquitously expressed protein with anti oxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. J Biol Chem 76 (2001) 44444-44449
15. Moore E.H., Napolitano M., Prosperi A., et al. Incorporation of lycopene into chylomicron remnant-like particles enhances their induction of lipid accumulation in macrophages. Biochem Biophys Res Commun 312 (2003) 1216-1219
16. Ng C.J., Bourquard N., Grijalva V., et al. Paraoxonase-2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins: anti-atherogenic role for paraoxonase-2. J Biol Chem 281 (2006) 29491-29500
17. Napolitano M., Avella M., Botham K.M., and Bravo E. Chylomicrons remnant induction of lipid accumulation in J774 A. 1 macrophages is associated with up-regulation of triacylglycerol synthesis which is not dependent on oxidation of the particles. Biochim Biophys Acta 1631 (2003) 255-264
18. Vaziri N.D., Kim C.H., Phan D., Kim S., and Liang K. Up-regulation of hepatic acylCoA: diacylglycerol acyltransferase-1 (DGAT1) expression in neophrotic syndrome. Kidney Int 66 (2004) 262-267
19. Buege J.A., and Aust S.D. Microsomal lipid peroxidation. Methods Enzymol 52 (1978) 302-310
20. Kaplan M., Kerry R., Aviram M., and Hayek T. High glucose concentration increase macrophage cholesterol biosynthesis in diabetes through activation of the sterol regulatory element binding protein: inhibitory effect of insulin. J Cardiovasc Pharmacol 52 4 (2008) 324-332
21. Rosenblat M., Draganov D., Watson C.E., Bisgaier C.L., La Du B.N., and Aviram M. Mouse macrophage paraoxonase 2 activity is increased whereas cellular paraxonase 3 activity is decreased under oxidative stress. Arterioscler Thromb Vasc Biol 23 (2003) 468-474
22. Vejrazka M., Micek R., and Stipek S. Apocynin inhibits NADPH oxidase in phagocytes but stimulates ROS production in non-phagocytic cell. Biochim Biophys Acta 1722 (2005) 143-147
23. Robert V., Farese Jr., Sylvaine C., and Smith S.J. Triglyceride synthesis: insights from the cloning of diacylglycerosl acyltransferase. Curr Opin Lipidol 11 (2000) 229-234
24. Casaschi A., Maiyoh G.K., Adeli K., and Theriault A.G. Increased diacylglycerol acyltransferase activity is associated with triglyceride accumulation in tissues of diet-induced insulin-resistant hyperlipidemic hamsters. Metastasis Clin Exp 54 (2005) 403-409
25. Meegalla R.L., Billheimer J.T., and Cheng D. Concerted elevation of acyl-coenzyme A:diacylglycerol acyltransferase (DGAT) activity through independent stimulation of mRNA expression of DGAT1 and DGAT2 by carbohydrate and insulin. Biochem Biophys Res Commun 298 (2002) 317-323
26. van der Vlies D., Pap E.H., Post J.A., Celis J.E., and Wirtz K.W. Ednoplasmatic reticulum resident proteins of normal human dermal fibroblasts are the major targets for oxidative stress induced by hydrogen peroxide. Biochem J 366 (2002) 825-830
27. Gorlach A., Klappa P., and Kietzmann T. The endoplasmatic reticulum: folding, calcium homeostasis, signaling, and redox control. Antioxid Redox Signal 8 (2006) 1391-1418
28. Yamagishi S., and Takeuchi M. Nifedipine inhibit gene expression of receptor for advanced glycation end products (RAGE) in endothelial cells by suppressing reactive oxygen species generation. Drugs Exp Clin Res 30 (2004) 169-175
29. Fuhrman B., Khateeb J., Shiner M., et al. Urokinase plasminogen activator upregulates paraoxonase 2 expression in macrophages via an NADPH oxidase-dependent mechanism. Arterioscler Thromb Vasc Biol 28 (2008) 1361-1367
30. Semenkovich C.F. Insulin resistance and atherosclerosis. J Clin Invest 116 (2006) 1813-1822